Home-based screening for undiagnosed heart failure
Official title: Uppsala Self-SCREENing of Heart Failure Study
Run by Uppsala University · NCT06940544 · Data updated 2026-11-12
This study tests a new home screening method to see if it can help find undiagnosed heart failure in high-risk patients better than regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Uppsala University Academic / other |
| Locations | 1 site (Uppsala) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2026 |
| Registry record updated | April 23, 2025 |
| Trial ID | NCT06940544 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40 and older with symptoms of heart failure and at least two risk factors for the condition.
✕Probably not a fit
Patients who have previously been diagnosed with heart failure or have undergone renal replacement therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates a stepwise multimodal home-based screening strategy using rapid point-of-care testing to detect undiagnosed heart failure in high-risk patients. It compares this approach to usual care to determine if it increases the diagnosis of heart failure within six months and leads to more patients receiving guideline-directed medical therapy. The study also evaluates the long-term impact of earlier diagnosis on hospitalizations, mortality, functional capacity, quality of life, and healthcare costs over one, two, and five years.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnosis and treatment of heart failure, improving patient outcomes and quality of life.
How similar studies have gone: Other studies have shown promise in home-based screening approaches for heart failure, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age ≥40 years, and at least one of the following symptoms of HF, and at least two risk factors for HF: Symptoms * Dyspnoea on exertion * Dyspnoea at rest * Orthopnoea * Paroxysmal nocturnal dyspnoea * Reduced exercise tolerance, increased time to recover after exercise * Fatigue, tiredness * Ankle swelling Risk factors * Diabetes (type 1 or type 2) * Coronary artery disease (myocardial infarction or coronary artery bypass grafting or percutaneous coronary intervention) * Persistent or permanent atrial fibrillation (not paroxysmal atrial fibrillation) * Previous ischemic or embolic stroke * Peripheral arterial disease (previous surgical or percutaneous revascularisation) * Chronic kidney disease * Regular loop diuretic use (any dose at any dosing interval) for \>30 days * COPD (diagnosis by respiratory physician, radiological emphysema or treatment with advocated COPD therapy) Exclusion Criteria: * Previous diagnosis of HF * Previous renal replacement therapy * Inability to comply with study procedures or provide informed consent
Where it's running
-
Uppsala Akademiska Hospital
Uppsala, Sweden Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.